Go Pro

Nutex Health (NASDAQ:NUTX) Coverage Initiated by Analysts at B. Riley Financial

Nutex Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • B. Riley Financial initiated coverage of Nutex Health with a “buy” rating and a $325 price target, implying approximately 69.5% upside from the reported share price.
  • Analyst sentiment is broadly positive: Nutex Health has a consensus “Buy” rating and an average target price of $317.50, supported by ratings from Zacks Research and Lake Street Capital.
  • Nutex Health shares fell 3.0% to $191.74, despite reporting quarterly EPS of $9.38—well above the $4.95 consensus estimate. Institutional investors own 5.32% of the company.
  • Interested in Nutex Health? Here are five stocks we like better.

Equities researchers at B. Riley Financial started coverage on shares of Nutex Health (NASDAQ:NUTX - Get Free Report) in a note issued to investors on Friday. The firm set a "buy" rating and a $325.00 price target on the stock. B. Riley Financial's price objective suggests a potential upside of 69.50% from the stock's current price.

A number of other equities analysts have also commented on NUTX. Weiss Ratings raised shares of Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a research report on Tuesday, July 28th. Zacks Research upgraded shares of Nutex Health from a "hold" rating to a "strong-buy" rating in a research note on Monday, August 24th. Lake Street Capital reissued a "buy" rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Finally, Wall Street Zen cut shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $317.50.

Check Out Our Latest Report on Nutex Health

Nutex Health Stock Down 3.0%

NASDAQ NUTX traded down $5.95 during trading on Friday, hitting $191.74. 20,394 shares of the company traded hands, compared to its average volume of 170,225. Nutex Health has a 12 month low of $80.53 and a 12 month high of $204.00. The business has a fifty day simple moving average of $175.06 and a 200 day simple moving average of $136.35. The company has a market capitalization of $1.31 billion, a P/E ratio of 7.53 and a beta of 0.28. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The company had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million.

Institutional Trading of Nutex Health

Institutional investors have recently modified their holdings of the company. Kilter Group LLC acquired a new position in shares of Nutex Health in the second quarter valued at $27,000. Allworth Financial LP acquired a new stake in Nutex Health during the second quarter worth $35,000. Islay Capital Management LLC bought a new stake in Nutex Health in the 4th quarter valued at $34,000. BNP Paribas Financial Markets raised its stake in shares of Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company's stock valued at $40,000 after buying an additional 290 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in shares of Nutex Health by 752.4% in the 4th quarter. Royal Bank of Canada now owns 358 shares of the company's stock valued at $59,000 after buying an additional 316 shares in the last quarter. Institutional investors and hedge funds own 5.32% of the company's stock.

About Nutex Health

(Get Free Report)

Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

Read More

Analyst Recommendations for Nutex Health (NASDAQ:NUTX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines